CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
breast biopsy occurs if biopsy is needed....
Port Orange, Florida, United States and 3 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Orlando, Florida, United States and 76 other locations
contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis -...
The Villages, Florida, United States and 9 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Orlando, Florida, United States and 107 other locations
effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast...
Phase 2
Lakeland, Florida, United States and 17 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Orlando, Florida, United States and 316 other locations
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...
Phase 1
Orlando, Florida, United States and 20 other locations
positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...
Phase 1
Lake Mary, Florida, United States and 63 other locations
growth factor 2 negative (ER+/HER2-) locally advanced or metastatic breast cancer. The main goals of this study are to:* Identify t...
Phase 1
Orlando, Florida, United States and 8 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
Orlando, Florida, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal